High neutralizing potency of swine glyco-humanized polyclonal antibodies against SARS-CoV-2

Perfusion of convalescent plasma (CP) has demonstrated a potential to improve the pneumonia induced by SARS-CoV-2, but procurement and standardization of CP are barriers to its wide usage. Many monoclonal antibodies (mAbs) have been developed but appear insufficient to neutralize SARS-CoV-2 unless t...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:bioRxiv
Main Authors: Vanhove, Bernard, Duvaux, Odile, Rousse, Juliette, Royer, Pierre-Joseph, Evanno, Gwénaëlle, Ciron, Carine, Lheriteau, Elsa, Vacher, Laurent, Gervois, Nadine, Oger, Romain, Jacques, Yannick, Conchon, Sophie, Salama, Apolline, Duchi, Roberto, Lagutina, Irina, Perota, Andrea, Delahaut, Philippe, Ledure, Matthieu, Paulus, Melody, So, Ray T., Mok, Chris Ka-Pun, Bruzzone, Roberto, Bouillet, Marc, Brouard, Sophie, Cozzi, Emanuele, Galli, Cesare, Blanchard, Dominique, Bach, Jean-Marie, Soulillou, Jean-Paul
Formato: Artigo
Idioma:Inglês
Publicado em: Cold Spring Harbor Laboratory 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8132227/
https://ncbi.nlm.nih.gov/pubmed/34013271
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1101/2020.07.25.217158
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados